123 related articles for article (PubMed ID: 19049640)
1. Binding of human papillomavirus type 16 to heparan sulfate is inhibited by mucosal antibodies from patients with low-grade squamous intraepithelial lesions but not from cervical cancer patients.
Lopez TV; Cancio C; Cruz-Talonia F; Ruiz B; Sapp M; Rocha-Zavaleta L
FEMS Immunol Med Microbiol; 2008 Nov; 54(2):167-76. PubMed ID: 19049640
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of human papillomavirus genotypes, and mucosal IgA anti-viral responses in women with cervical ectopy.
Monroy OL; Aguilar C; Lizano M; Cruz-Talonia F; Cruz RM; Rocha-Zavaleta L
J Clin Virol; 2010 Jan; 47(1):43-8. PubMed ID: 19906557
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study.
Velentzis LS; Sitas F; O'Connell DL; Darlington-Brown J; Egger S; Sinha R; Banks E; Frazer IH; Canfell K
BMC Infect Dis; 2014 Dec; 14():3861. PubMed ID: 25528152
[TBL] [Abstract][Full Text] [Related]
5. Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions.
Strickler HD; Schiffman MH; Eklund C; Glass AG; Scott DR; Sherman ME; Wacholder S; Kurman RJ; Manos MM; Schiller JT; Dillner J
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):183-8. PubMed ID: 9138661
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses to HPV16 virus-like particles in women with cervical intraepithelial neoplasia infected with a variant HPV16.
Ellis JR; Etherington I; Galloway D; Luesley D; Young LS
Lancet; 1997 Apr; 349(9058):1069-70. PubMed ID: 9107250
[No Abstract] [Full Text] [Related]
7. Mucosal IgG and IgA responses to human papillomavirus type 16 capsid proteins in HPV16-infected women without visible pathology.
Rocha-Zavaleta L; Pereira-Suarez AL; Yescas G; Cruz-Mimiaga RM; Garcia-Carranca A; Cruz-Talonia F
Viral Immunol; 2003; 16(2):159-68. PubMed ID: 12828867
[TBL] [Abstract][Full Text] [Related]
8. Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study.
Bierl C; Karem K; Poon AC; Swan D; Tortolero-Luna G; Follen M; Wideroff L; Unger ER; Reeves WC
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S262-8. PubMed ID: 16229879
[TBL] [Abstract][Full Text] [Related]
9. Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection.
Haupt RM; Wheeler CM; Brown DR; Garland SM; Ferris DG; Paavonen JA; Lehtinen MO; Steben M; Joura EA; Giacoletti KE; Radley DR; James MK; Saah AJ; Sings HL;
Int J Cancer; 2011 Dec; 129(11):2632-42. PubMed ID: 21491420
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunoglobulin-A and -G responses to oncogenic human papilloma virus capsids.
Sasagawa T; Rose RC; Azar KK; Sakai A; Inoue M
Int J Cancer; 2003 Apr; 104(3):328-35. PubMed ID: 12569556
[TBL] [Abstract][Full Text] [Related]
11. Association of antibody to E2 protein of human papillomavirus and p16
Chuerduangphui J; Pientong C; Swangphon P; Luanratanakorn S; Sangkomkamhang U; Tungsiriwattana T; Kleebkaow P; Burassakarn A; Ekalaksananan T
Med Oncol; 2018 May; 35(6):93. PubMed ID: 29744680
[TBL] [Abstract][Full Text] [Related]
12. Local applications of GM-CSF induce the recruitment of immune cells in cervical low-grade squamous intraepithelial lesions.
Hubert P; Doyen J; Capelle X; Arafa M; Renoux V; Bisig B; Seidel L; Evrard B; Bousarghin L; Gerday C; Boniver J; Foidart JM; Delvenne P; Jacobs N
Am J Reprod Immunol; 2010 Aug; 64(2):126-36. PubMed ID: 20367631
[TBL] [Abstract][Full Text] [Related]
13. HPV-16 E7-Specific Cellular Immune Response in Women With Cervical Intraepithelial Lesion Contributes to Viral Clearance: A Cross-Sectional and Longitudinal Clinical Study.
Zhang L; Shi X; Zhang Q; Mao Z; Shi X; Zhou J; Jian A; Zhu R; Jiang S; Lu W
Front Immunol; 2021; 12():768144. PubMed ID: 35095843
[TBL] [Abstract][Full Text] [Related]
14. Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).
Kaufmann AM; Nieland JD; Jochmus I; Baur S; Friese K; Gabelsberger J; Gieseking F; Gissmann L; Glasschröder B; Grubert T; Hillemanns P; Höpfl R; Ikenberg H; Schwarz J; Karrasch M; Knoll A; Küppers V; Lechmann M; Lelle RJ; Meissner H; Müller RT; Pawlita M; Petry KU; Pilch H; Walek E; Schneider A
Int J Cancer; 2007 Dec; 121(12):2794-800. PubMed ID: 17721997
[TBL] [Abstract][Full Text] [Related]
15. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
[TBL] [Abstract][Full Text] [Related]
16. Physical and methylation status of human papillomavirus 16 in asymptomatic cervical infections changes with malignant transformation.
Dutta S; Chakraborty C; Dutta AK; Mandal RK; Roychoudhury S; Basu P; Panda CK
J Clin Pathol; 2015 Mar; 68(3):206-11. PubMed ID: 25563334
[TBL] [Abstract][Full Text] [Related]
17. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
Matsumoto K; Yoshikawa H; Yasugi T; Nakagawa S; Kawana K; Takeoka A; Yaegashi N; Iwasaka T; Kanazawa K; Taketani Y; Kanda T
J Med Virol; 2003 Mar; 69(3):441-6. PubMed ID: 12526056
[TBL] [Abstract][Full Text] [Related]
18. HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions.
Mehlhorn G; Hautmann SK; Koch MC; Strehl JD; Hartmann A; Hilfrich R; Beckmann MW; Griesser H
Anticancer Res; 2014 Sep; 34(9):5127-32. PubMed ID: 25202103
[TBL] [Abstract][Full Text] [Related]
19. Local cervical immunity in women with low-grade squamous intraepithelial lesions and immune responses after abrasion.
Ekalaksananan T; Malat P; Pientong C; Kongyingyoes B; Chumworathayi B; Kleebkaow P
Asian Pac J Cancer Prev; 2014; 15(10):4197-201. PubMed ID: 24935370
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological implications of human papilloma virus (HPV) L1 capsid protein immunoreactivity in HPV16-positive cervical cytology.
Lee SJ; Lee AW; Kang CS; Park JS; Park DC; Ki EY; Lee KH; Yoon JH; Hur SY; Kim TJ
Int J Med Sci; 2014; 11(1):80-6. PubMed ID: 24396289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]